USPTO 2015–2025 USPTO PatentsView US Corporation

Bannack Medical Llc

USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y02A (TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE).

17
Total patents granted
3
CPC technology areas
3.4
Avg claims per patent
-
5-year filing velocity

The verdict

Bannack holds 17 US patents across 3 technology areas, rank #16,613 of 50,000 tracked assignees.

#16,613
of 50,000 US assignees by volume
Top 42%
by Innovation Score (38.1/100)
3.4
avg claims per patent

Portfolio overview

BANNACK MEDICAL LLC has been granted 17 US utility patents between 2022 and 2025, placing BANNACK MEDICAL LLC at rank #16,613 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 3.4 claims per patent with primary concentration in Y02A (TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE). As a US Corporation, BANNACK MEDICAL LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 38.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 17 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. BANNACK MEDICAL LLC's 3.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark BANNACK MEDICAL LLC against peers pursuing similar technology classes.

How does BANNACK compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows BANNACK holds 17 patents, placing it at rank #16,613 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

BANNACK's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

0246810 2022202320242025 4
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
BANNACK MEDICAL LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 4 23.5%
2023 1 5.9%
2024 8 47.1%
2025 4 23.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple

Where it ranks

Overall rank by patents

#16,613

Across all tracked assignees

Innovation Score

38.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does BANNACK MEDICAL LLC hold?
BANNACK MEDICAL LLC holds 17 US granted patents filed between 2022 and 2025, spanning 3 technology areas.
What is BANNACK MEDICAL LLC's Innovation Score?
BANNACK MEDICAL LLC has an Innovation Score of 38.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does BANNACK MEDICAL LLC focus on?
BANNACK MEDICAL LLC's top technology area is Y02A (TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE) with 3 patents. The company has filed patents in 3 CPC subclasses total.
Is BANNACK MEDICAL LLC's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for BANNACK MEDICAL LLC.
What does claim depth mean for BANNACK MEDICAL LLC's patents?
BANNACK MEDICAL LLC's patents average 3.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the BANNACK MEDICAL LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Bannack's 17 grants land it in the top 42% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Bannack ranks #16,613 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in Y02A - see who else leads that technology area. Y02A leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov